{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T03:44:52Z","timestamp":1774237492283,"version":"3.50.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","award":["PIP 11220200102959CO"],"award-info":[{"award-number":["PIP 11220200102959CO"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012478","name":"Universidad Nacional de C\u00f3rdoba Secretaria de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021778","name":"Agencia Nacional De Promocion Cientifica Y Tecnologica","doi-asserted-by":"publisher","award":["PICT 2018 #00673"],"award-info":[{"award-number":["PICT 2018 #00673"]}],"id":[{"id":"10.13039\/501100021778","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021778","name":"Agencia Nacional De Promocion Cientifica Y Tecnologica","doi-asserted-by":"publisher","award":["01082"],"award-info":[{"award-number":["01082"]}],"id":[{"id":"10.13039\/501100021778","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Veterinary Science"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.rvsc.2025.105692","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T06:00:25Z","timestamp":1747029625000},"page":"105692","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Differential innate immune activation by four different CpG-ODNs in porcine and murine cells: Implications for vaccine design"],"prefix":"10.1016","volume":"191","author":[{"given":"Giuliana","family":"Vedelago","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luz M.","family":"Palacios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sof\u00eda D.","family":"Castell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constanza","family":"Marin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico N.","family":"Ruiz Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Esperanza","family":"Felici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicol\u00e1s D.","family":"Dho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel A.","family":"Allemandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago D.","family":"Palma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Mor\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando A.","family":"Bessone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrisio E.","family":"Alustiza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda I.","family":"Crespo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Belkys A.","family":"Maletto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rvsc.2025.105692_bb0005","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2021.654289","article-title":"Novel vaccine Technologies in Veterinary Medicine: a herald to human medicine vaccines","volume":"8","author":"Aida","year":"2021","journal-title":"Front. Vet. Sci."},{"issue":"7872","key":"10.1016\/j.rvsc.2025.105692_bb0010","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41586-021-03791-x","article-title":"Systems vaccinology of the BNT162b2 mRNA vaccine in humans","volume":"596","author":"Arunachalam","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.rvsc.2025.105692_bb0015","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.4049\/jimmunol.1600672","article-title":"Characterization and transcriptomic analysis of porcine blood conventional and Plasmacytoid dendritic cells reveals striking species-specific differences","volume":"197 (12):","author":"Auray","year":"2016","journal-title":"J Immunol."},{"key":"10.1016\/j.rvsc.2025.105692_bb0020","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.intimp.2014.02.033","article-title":"Systemic immunotoxicity reactions induced by adjuvanted vaccines","volume":"20(1):","author":"Batista-Duharte","year":"2014","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.rvsc.2025.105692_bb0025","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.3389\/fimmu.2017.01044","article-title":"Porcine B cell subset responses to toll-like receptor ligands","volume":"8","author":"Braun","year":"2017","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.rvsc.2025.105692_bb0030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1089\/vim.2017.0049","article-title":"Adjuvants for animal vaccines","volume":"31","author":"Burakova","year":"2018","journal-title":"Viral Immunol."},{"issue":"1\u20132","key":"10.1016\/j.rvsc.2025.105692_bb0035","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.vetimm.2005.04.003","article-title":"Interleukin-12 (IL-12) ameliorates the effects of porcine respiratory and reproductive syndrome virus (PRRSV) infection","volume":"107","author":"Carter","year":"2005","journal-title":"Vet Immunol Immunopathol."},{"key":"10.1016\/j.rvsc.2025.105692_bb0040","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.3389\/fimmu.2018.02319","article-title":"Class-B CpG-ODN formulated with a nanostructure induces type I interferons-dependent and CD4+ T cell-independent CD8+ T-cell response against unconjugated protein antigen","volume":"9","author":"Chiodetti","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.rvsc.2025.105692_bb0045","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.3389\/fimmu.2020.01075","article-title":"Adjuvant effect of toll-like receptor 9 activation on Cancer immunotherapy using checkpoint blockade","volume":"11","author":"Chuang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.rvsc.2025.105692_bb0050","article-title":"IL-6 production following vaccination in pigs\u2014an additional immune response parameter for assessing FMD vaccine efficacy?","volume":"29(29-30):4704-8","author":"Cox","year":"2011","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.rvsc.2025.105692_bb0055","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s13346-021-00924-7","article-title":"Development of vaccine formulations: past, present, and future","volume":"11","author":"D\u2019Amico","year":"2021","journal-title":"Drug Deliv and Transl Res"},{"issue":"1\u20132","key":"10.1016\/j.rvsc.2025.105692_bb0060","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0165-2427(96)05773-X","article-title":"Molecular cloning and mRNA expression of porcine interleukin-12","volume":"57","author":"Foss","year":"1997","journal-title":"Vet Immunol Immunopathol"},{"issue":"8","key":"10.1016\/j.rvsc.2025.105692_bb0065","article-title":"The new porcine epidemic diarrhea virus outbreak may mean that existing commercial vaccines are not enough to fully protect against the epidemic strains","volume":"5","author":"Gao","year":"2021","journal-title":"Front. Vet. Sci."},{"issue":"7","key":"10.1016\/j.rvsc.2025.105692_bb0070","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1586\/14760584.2014.920236","article-title":"Toll-like receptor-based adjuvants: enhancing the immune response to vaccines against infectious diseases of chicken","volume":"13","author":"Gupta","year":"2014","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"10.1016\/j.rvsc.2025.105692_bb0075","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1365-2567.2004.01856.x","article-title":"Type-a CpG oligonucleotides activate exclusively porcine natural interferon-producing cells to secrete interferon-\u03b1, tumour necrosis factor-\u03b1 and interleukin-12","volume":"112","author":"Guzylack-Piriou","year":"2004","journal-title":"Immunology"},{"key":"10.1016\/j.rvsc.2025.105692_bb0080","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2147\/IJN.S114477","article-title":"CpG oligodeoxynucleotide nanomedicines for the prophylaxis or treatment of cancers, infectious diseases, and allergies","volume":"12","author":"Hanagata","year":"2017","journal-title":"Int J Nanomedicine"},{"issue":"6813","key":"10.1016\/j.rvsc.2025.105692_bb0085","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/35047123","article-title":"A toll-like receptor recognizes bacterial DNA","volume":"408","author":"Hemmi","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.rvsc.2025.105692_bb0090","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.3389\/fmicb.2016.01992","article-title":"CpG Oligodeoxynucleotides induce differential cytokine and chemokine gene expression profiles in Dapulian and landrace pigs","volume":"7","author":"Hu","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.rvsc.2025.105692_bb0095","doi-asserted-by":"crossref","DOI":"10.1089\/108729003768247628","article-title":"Safety of CpG oligodeoxynucleotides in veterinary species","author":"Ioannou","year":"2003","journal-title":"Antisense Nucleic Acid Drug Dev. 13(3):157-67."},{"issue":"4","key":"10.1016\/j.rvsc.2025.105692_bb0100","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0378-1135(00)00300-X","article-title":"Response of porcine peripheral blood mononuclear cells to CpG-containing oligodeoxynucleotides","volume":"78","author":"Kamstrup","year":"2001","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.rvsc.2025.105692_bb0105","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/978-1-0716-0872-2_4","article-title":"CpG Oligonucleotides as Vaccine Adjuvants","volume":"2197","author":"Kayraklioglu","year":"2021","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.rvsc.2025.105692_bb0110","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.0105-2896.2004.00148.x","article-title":"Use of CpG oligodeoxynucleotides as immune adjuvants","volume":"199","author":"Klinman","year":"2004","journal-title":"Immunol Rev"},{"issue":"6","key":"10.1016\/j.rvsc.2025.105692_bb0115","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nrd2059","article-title":"Therapeutic potential of toll-like receptor 9 activation","volume":"5","author":"Krieg","year":"2006","journal-title":"Nat Rev Drug Discov."},{"issue":"2","key":"10.1016\/j.rvsc.2025.105692_bb0120","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1089\/nat.2012.0340","article-title":"CpG still rocks! Update on an accidental drug","volume":"22","author":"Krieg","year":"2012","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.rvsc.2025.105692_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.tvjl.2014.11.017","article-title":"Expression of toll-like receptor 9 (TLR9) in the lungs and lymphoid tissue of pigs","author":"Kuzemtseva","year":"2015","journal-title":"Vet J. 203(2):259-61."},{"key":"10.1016\/j.rvsc.2025.105692_bb0130","article-title":"Immunostimulatory activities of CpG-Oligodeoxynucleotides in Teleosts: toll-like receptors 9 and 21","volume":"10:179","author":"Lai","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.rvsc.2025.105692_bb0135","doi-asserted-by":"crossref","DOI":"10.1080\/14760584.2021.1908133","article-title":"CpG-Adjuvanted hepatitis B vaccine (HEPLISAV-B\u00ae) update","author":"Lee","year":"2021","journal-title":"Expert Rev Vaccines. 20(5):487-495."},{"key":"10.1016\/j.rvsc.2025.105692_bb0140","article-title":"CpG 1018 is an effective adjuvant for influenza nucleoprotein","author":"Li","year":"2023","journal-title":"Vaccines (Basel). 11(3):649."},{"key":"10.1016\/j.rvsc.2025.105692_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetimm.2016.05.003","article-title":"Response of immune response genes to adjuvants poly [di(sodium carboxylatoethylphenoxy)phosphazene] (PCEP), CpG oligodeoxynucleotide and emulsigen at intradermal injection site in pigs","author":"Magiri","year":"2016","journal-title":"Vet Immunol Immunopathol. 175:57-63."},{"issue":"5","key":"10.1016\/j.rvsc.2025.105692_bb0150","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3109\/08923973.2013.828743","article-title":"Immunotherapeutic potential of CpG oligodeoxynucleotides in veterinary species","volume":"35","author":"Manuja","year":"2013","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1016\/j.rvsc.2025.105692_bb0155","article-title":"Improved biodistribution and enhanced immune response of subunit vaccine using a nanostructure formed by self-assembly of ascorbyl palmitate","volume":"58","author":"Marin","year":"2024","journal-title":"Nanomedicine."},{"issue":"2","key":"10.1016\/j.rvsc.2025.105692_bb0160","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1089\/dna.2005.24.63","article-title":"Superior activity of the type C class of ISS in vitro and in vivo across multiple species","volume":"24","author":"Marshall","year":"2005","journal-title":"DNA Cell Biol"},{"key":"10.1016\/j.rvsc.2025.105692_bb0165","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.590054","article-title":"CpG adjuvant in allergen-specific immunotherapy: finding the sweet spot for the induction of immune tolerance","volume":"12","author":"Montamat","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.rvsc.2025.105692_bb0170","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13567-015-0209-9","article-title":"Efficacy of a live attenuated vaccine in classical swine fever virus postnatally persistently infected pigs","volume":"46","author":"Mu\u00f1oz-Gonz\u00e1lez","year":"2015","journal-title":"Vet Res."},{"key":"10.1016\/j.rvsc.2025.105692_bb0175","series-title":"Special Issue: Proceedings of the 9th International veterinary immunology symposium (9th IVIS)","first-page":"85","article-title":"TLR9 agonists: immune mechanisms and therapeutic potential in domestic animals. Veterinary immunology and immunopathology","volume":"148(1-2)","author":"Mutwiri","year":"2012"},{"key":"10.1016\/j.rvsc.2025.105692_bb0180","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0165-2427(02)00246-5","article-title":"Biological activity of immunostimulatory CpG DNA motifs in domestic animals","volume":"91","author":"Mutwiri","year":"2003","journal-title":"Vet Immunol. Immunopathol."},{"issue":"Pt 6","key":"10.1016\/j.rvsc.2025.105692_bb0185","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1099\/0022-1317-82-6-1263","article-title":"Reversion of a live porcine reproductive and respiratory syndrome virus vaccine investigated by parallel mutations","volume":"82","author":"Nielsen","year":"2001","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.rvsc.2025.105692_bb0190","doi-asserted-by":"crossref","first-page":"1428713","DOI":"10.3389\/fvets.2024.1428713","article-title":"Safety and efficacy of toll-like receptor agonists as therapeutic agents and vaccine adjuvants for infectious diseases in animals: a systematic review","volume":"11","author":"Oboge","year":"2024","journal-title":"Front. Vet. Sci."},{"issue":"6","key":"10.1016\/j.rvsc.2025.105692_bb0195","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41573-021-00163-y","article-title":"Emerging concepts in the science of vaccine adjuvants","volume":"20","author":"Pulendran","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.rvsc.2025.105692_bb0200","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1089\/108729001753231713","article-title":"CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved","volume":"11","author":"Rankin","year":"2001","journal-title":"Antisense Nucleic Acid Drug Dev."},{"issue":"12","key":"10.1016\/j.rvsc.2025.105692_bb0205","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/nm.3409","article-title":"Key roles of adjuvants in modern vaccines","volume":"19","author":"Reed","year":"2013","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.rvsc.2025.105692_bb0210","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1016\/j.biomaterials.2013.12.002","article-title":"Adjuvant activity of CpG-ODN formulated as a liquid crystal","volume":"35","author":"S\u00e1nchez Vallecillo","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.rvsc.2025.105692_bb0215","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jconrel.2015.07.008","article-title":"A liquid crystal of ascorbyl palmitate, used as vaccine platform, provides sustained release of antigen and has intrinsic pro-inflammatory and adjuvant activities which are dependent on MyD88 adaptor protein","volume":"214","author":"S\u00e1nchez Vallecillo","year":"2015","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.rvsc.2025.105692_bb0220","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41541-022-00486-w","article-title":"A CpG 1018 adjuvanted neuraminidase vaccine provides robust protection from influenza virus challenge in mice","volume":"7","author":"Strohmeier","year":"2022","journal-title":"NPJ Vaccines"},{"issue":"5","key":"10.1016\/j.rvsc.2025.105692_bb0225","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1080\/14760584.2021.1927724","article-title":"Type I and II interferons toward ideal vaccine and immunotherapy","volume":"20","author":"Temizoz","year":"2021","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.rvsc.2025.105692_bb0230","first-page":"75","article-title":"Adjuvants and adjuvanticity. Vaccines for","volume":"10:","author":"Tizard","year":"2020","journal-title":"Veterinarians"},{"key":"10.1016\/j.rvsc.2025.105692_bb0235","article-title":"Types of vaccines for animals","author":"Tizard","year":"2023","journal-title":"MSD Vet. Manual."},{"issue":"21","key":"10.1016\/j.rvsc.2025.105692_bb0240","doi-asserted-by":"crossref","first-page":"12162","DOI":"10.1073\/pnas.211423598","article-title":"TNF-\u03b1-dependent maturation of local dendritic cells is critical for activating the adaptive immune response to virus infection","volume":"98","author":"Trevejo","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"1\u20132","key":"10.1016\/j.rvsc.2025.105692_bb0245","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.vetimm.2004.12.020","article-title":"Porcine-specific CpG-oligodeoxynucleotide activates B-cells and increases the expression of MHC-II molecules on lymphocytes","volume":"105","author":"Van der Stede","year":"2005","journal-title":"Vet. Immunol. Immunopathol."},{"issue":"1\u20132","key":"10.1016\/j.rvsc.2025.105692_bb0250","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.vetimm.2004.09.016","article-title":"Immunostimulatory capacity of DNA vaccine vectors in porcine PBMC: a specific role for CpG-motifs?","volume":"103","author":"Verfaillie","year":"2005","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.rvsc.2025.105692_bb0255","doi-asserted-by":"crossref","first-page":"1043109","DOI":"10.3389\/fimmu.2023.1043109","article-title":"New-age vaccine adjuvants, their development, and future perspective","volume":"14","author":"Verma","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.rvsc.2025.105692_bb0260","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/eji.200324032","article-title":"Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities","volume":"34","author":"Vollmer","year":"2004","journal-title":"Eur. J. Immunol."},{"issue":"6","key":"10.1016\/j.rvsc.2025.105692_bb0265","article-title":"Attenuated porcine reproductive and respiratory syndrome virus regains its fatal virulence by serial passaging in pigs or porcine alveolar macrophages to increase its adaptation to target cells","volume":"10","author":"Wang","year":"2022","journal-title":"Microbiol Spectr"},{"issue":"5","key":"10.1016\/j.rvsc.2025.105692_bb0270","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1359-6101(03)00043-1","article-title":"The biology of IL-12: coordinating innate and adaptive immune responses","volume":"14","author":"Watford","year":"2003","journal-title":"Cytokine Growth Factor Rev."},{"issue":"1","key":"10.1016\/j.rvsc.2025.105692_bb0275","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3390\/pharmaceutics14010073","article-title":"CpG Oligodeoxynucleotides for anticancer monotherapy from preclinical stages to clinical trials","volume":"14","author":"Zhang","year":"2021","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.rvsc.2025.105692_bb0280","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41392-023-01557-7","article-title":"Vaccine adjuvants: mechanisms and platforms","volume":"8","author":"Zhao","year":"2023","journal-title":"Sig. Transduct. Target. Ther."}],"container-title":["Research in Veterinary Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034528825001663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034528825001663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T04:36:37Z","timestamp":1748320597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0034528825001663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":56,"alternative-id":["S0034528825001663"],"URL":"https:\/\/doi.org\/10.1016\/j.rvsc.2025.105692","relation":{},"ISSN":["0034-5288"],"issn-type":[{"value":"0034-5288","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential innate immune activation by four different CpG-ODNs in porcine and murine cells: Implications for vaccine design","name":"articletitle","label":"Article Title"},{"value":"Research in Veterinary Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rvsc.2025.105692","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105692"}}